Evidence map›Paper›PMID 20478760›Full record

ArticleEnvironmental health perspectives2010

HFE H63D polymorphism as a modifier of the effect of cumulative lead exposure on pulse pressure: the Normative Aging Study.

Aimin Zhang, Sung Kyun Park, Robert O Wright, Marc G Weisskopf, Bhramar Mukherjee, Huiling Nie, David Sparrow, Howard Hu

Open access · diamondAbstract read
In one paragraph

Article in Environmental health perspectives, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Medicina (Kaunas, Lithuania) · 2026
    Pooled it
  2. Alagebrium and Complications of Diabetes Mellitus.The Eurasian journal of medicine · 2019
    Review
  3. Oral nucleic acid therapy using multicompartmental delivery systems.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2018
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Aimin ZhangDepartment of Environmental Health Sciences, University of Michigan School of Public Health, Ann Arbor, Michigan, USA. aiminz@umich.edu
Sung Kyun Park
Robert O Wright
Marc G Weisskopf
Bhramar Mukherjee
Huiling Nie
David Sparrow
Howard Hu
Brigham and Women's Hospital · USUniversity of Michigan · USBoston University · USPurdue University West Lafayette · US

Funding

Zoledronic Acid in Treatment of Osteoporosis in PostmenoM01RR002635 · NCRR · BRIGHAM AND WOMEN'S HOSPITAL · PI GARBER, JUDY E. · 1985 to 2008
$48.4M
Translational Research Support CoreP30ES000002 · NIEHS · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI SUSAN A KORRICK · 1985 to 2026
$44.6M
VANADIUM AND HUMAN HEALTHP42ES005947 · NIEHS · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI KELSEY, KARL TIMOTHY · 1992 to 2006
$19.6M
ENVIRONMENTAL TOXICOLOGY PRE/POST DOCTORAL RES.TRAININGT32ES007062 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Justin Adam Colacino · 1985 to 2026
$10.5M
LEAD DOSE BIOMARKERS, REPRODUCTION, AND INFANT OUTCOMESR01ES007821 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PETERSON, KAREN EILEEN · 1998 to 2010
$4.7M
LEAD-GENE INTERACTIONS AND CONGNITIONR01ES005257 · NIEHS · BRIGHAM AND WOMEN'S HOSPITAL · PI WEISSKOPF, MARC G · 1991 to 2007
$4.2M
Environment, Novel Aging Outcomes, and GeneticsK01ES016587 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PARK, SUNG KYUN · 2009 to 2013
$622k
IN VIVO TOTAL BODY LEAD ANALYSIS BY X-RAY FLUORESCENCER44ES003918 · NIEHS · ABIOMED, INC. · PI MILDER, FREDRIC L · 1987 to 1988
–
NCRR NIH HHS M01 RR002635NCRR NIH HHS M01RR02635NIEHS NIH HHS 2R44 ES03918NIEHS NIH HHS K01 ES016587NIEHS NIH HHS K01-ES016587-01A1NIEHS NIH HHS P30 ES000002NIEHS NIH HHS P30-ES00002NIEHS NIH HHS P42 ES005947NIEHS NIH HHS P42-ES05947NIEHS NIH HHS R01 ES005257NIEHS NIH HHS R01 ES007821NIEHS NIH HHS R01-ES05257NIEHS NIH HHS R01-ES07821NIEHS NIH HHS T32 ES007062NIEHS NIH HHS T32 ES07062
6 · The paper itself

Abstract

backgroundCumulative lead exposure is associated with a widened pulse pressure (PP; the -difference between systolic and diastolic blood pressure), a marker of arterial stiffness and a predictor of cardiovascular disease. Polymorphisms in the hemochromatosis gene (HFE) have been shown to modify the impact of cumulative lead exposure on measures of adult cognition and cardiac function.

objectivesWe examined whether the HFE mutations modify the impact of lead on PP in -community-dwelling older men.

methodsWe examined 619 participants with a total of 1,148 observations of PP from a substudy of bone lead levels (a measure of cumulative exposure, measured by in vivo K-shell X-ray fluorescence) and health in the Normative Aging Study between 1991 and 2001. Linear mixed-effects regression models with random intercepts were constructed.

resultsOf the 619 subjects, 138 and 72 carried the HFE H63D and C282Y variants, respectively. After adjusting for age; education; alcohol intake; smoking; daily intakes of calcium, sodium, and potassium; total calories; family history of hypertension; diabetes; height; heart rate; high-density lipoprotein (HDL); total cholesterol:HDL ratio; and waist circumference, baseline bone lead levels were associated with steeper increases in PP in men with at least one H63D allele (p-interaction = 0.03 for tibia and 0.02 for patella) compared with men with only the wild types or C282Y variant.

conclusionsThe HFE H63D polymorphism, but not the C282Y mutation, appears to enhance susceptibility to the deleterious impact of cumulative lead on PP, possibly via prooxidative or pro-inflammatory mechanisms.

Indexed as

AdultAgedAged, 80 and overFemaleGenotypeHemochromatosis ProteinHistocompatibility Antigens Class IHumansLeadMaleMembrane ProteinsMiddle AgedPatellaPolymerase Chain ReactionPolymorphism, GeneticTibiaHemochromatosis ProteinHFE protein, humanHistocompatibility Antigens Class ILeadMembrane Proteins

Identifiers

PMID20478760
PMCPMC2944087
OpenAlexW2164530052

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.